This forum is intended to ensure patient safety remains on the agenda for the pharmaceutical industry; drug counterfeiting is on the rise globally and regulatory deadlines are approaching at pace.
Despite the US regulatory timescales being delayed until 2018, non-US regulatory deadlines remain set and so the pharmaceutical supply chain continues to be at a critical point.
All stakeholders including drug manufacturers and outsourcing suppliers will need to ensure that robust plans are in place to upgrade their production lines in compliance with DSCSA, EU Falsified Medicines Directive (FMD) and emerging market traceability deadlines.
PCI’s latest Serialisation and Anti-Counterfeiting forum will bring together some of the most experienced personnel from across the industry who will share learnings to date and best practices for executing an effective serialisation strategy, nearly one year on from these discussions at the previous forum in January 2017.
The forum will not only focus on serialisation in isolation, but anti-counterfeiting as a whole and how the industry should best approach this as an overall strategy.
PCI as a global leader in commercial packaging services provides extensive serialisation, anti-counterfeiting experience and serialised product to both domestic, and emerging global markets across an extensive multinational supply network.
During the forum, PCI’s Ian Parsonage, Senior Director of Global Serialisation, will present best practices in serialisation and anti-counterfeiting. Parsonage’s session will showcase directly relevant real-life experience on the subject, sharing lessons learned, case studies and key signposts to look out for.
Christoph Krähenbühl, Senior Director at leading European serialisation consulting firm 3C Integrity, will share his experience with respect to the State of Readiness, providing valuable insights on preparing for the industry’s global serialisation requirements.
Elliot Abreu, Senior VP at Xyntek and Frank Madden, Founder and CEO of Crest Solutions, will provide advice for pharmaceutical companies on succeeding in serialisation strategy development and implementation.
Xyntek is the US partner integrator for Antares Vision serialisation technologies and Crest Solutions operates as partner integrator for the European market, both able to demonstrate an extensive history of successful installations.
Carol Hammond, VP of Innovation at full service print and packaging supplier MPS will provide an overview of industry leading anti-counterfeiting material technologies to complement overall serialisation strategies.
Attendees will also have the opportunity to gain additional insights from presenters during an open Q&A session, where practical experiences and best practices will be discussed.
Finally, a live demonstration using real-life imported production equipment will be delivered by Antares, providing attendees with first-hand experience of serialisation in practice.
This latest event will highlight evolving industry regulations for the implementation of serialisation and anti-counterfeiting strategies, particularly the deadlines for compliance with the DSCSA in the US, as well as EU requirements and those of emerging markets including China, South Korea, Brazil.
Industry professionals from pharmaceutical and biotech companies affected by global serialisation requirements will benefit from attending the PCI Serialisation and Anti-Counterfeiting Forum.
Agenda information and event registration is available on the PCI website or email joanne.phelps@pciservices.com to register for free.
Featured companies
- Companies:
- Crest Solutions
- Antares Pharma Inc
- Multi Packaging Solutions
- 3C Integrity
